Compare STRO & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | LEGT |
|---|---|---|
| Founded | 2003 | 2023 |
| Country | United States | United States |
| Employees | 131 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.9M | 282.2M |
| IPO Year | N/A | N/A |
| Metric | STRO | LEGT |
|---|---|---|
| Price | $24.66 | $10.98 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.38 | N/A |
| AVG Volume (30 Days) | ★ 173.7K | 123.7K |
| Earning Date | 03-23-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.45 | N/A |
| P/E Ratio | ★ N/A | $35.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.52 | $10.44 |
| 52 Week High | $27.96 | $11.50 |
| Indicator | STRO | LEGT |
|---|---|---|
| Relative Strength Index (RSI) | 63.91 | 53.73 |
| Support Level | $0.76 | $10.84 |
| Resistance Level | $27.96 | $11.11 |
| Average True Range (ATR) | 2.27 | 0.04 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 63.15 | 29.41 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Legato Merger Corp III is a blank check company.